The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.
Christel Rousseaux, Noura El-Jamal, Mathurin Fumery, Caroline Dubuquoy, Olivier Romano, Denis Chatelain, Audrey Langlois, Benjamin Bertin, David Buob, Jean Frederic Colombel, Antoine Cortot, Pierre Desreumaux, Laurent Dubuquoy
文献索引:Plant Physiol. 147 , 1092-1109, (2008)
全文:HTML全文
摘要
Epidemiological evidences suggested that 5-aminosalicylic acid (5-ASA) therapy may prevent the development of colorectal cancer in inflammatory bowel disease patients. Our aim is to investigate whether peroxisome proliferator-activated receptor-γ (PPARγ) mediates the antineoplastic effects of 5-ASA. HT-29 and Caco-2 cells were treated by 5-ASA, rosiglitazone (PPARγ ligand) or etoposide (anticarcinogenic drug). Epithelial cell growth, proliferation and apoptosis were assessed by cell count, Ki-67 staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, respectively. The antineoplastic effect of 5-ASA was evaluated in a xenograft tumor model in SCID mice and in azoxymethane (AOM)-induced colon carcinogenesis in A/JOlaHsd mice. The role of PPARγ was examined by administration of PPARγ antagonist, GW9662 and in PPAR knockdown cells. Compared with untreated cells, treatment of HT-29 cells by 5-ASA inhibited significantly cell growth and cell proliferation (respectively, 60% and 63%) and induced apoptosis in 75% of cells. These effects were abolished by co-treatment with GW9662 and blunted in PPAR knockdown cells. Contrarily to etoposide, similar inhibitory effects of GW9662 were obtained in HT-29 cells treated with rosiglitazone. In the xenograft model, GW9662 abolished the therapeutic effect of 5-ASA, which decreased tumor weight and volume by 80% in SCID mice compared with untreated mice. In A/JOlaHsd mice, 5-ASA suppressed colon carcinogenesis by decreasing the number of aberrant crypt foci (75%) and aberrant crypts (22%) induced by AOM treatment with an absence of 5-ASA response after GW9662 administration. In conclusion, 5-ASA exerts potent antineoplastic effects that are mediated through PPARγ. These data provide new rational for designing more effective and safe antineoplastic PPARγ ligands with topical effects.
相关化合物
相关文献:
2014-02-01
[Arthritis Rheumatology 66(2) , 273-83, (2014)]
1982-11-01
[Cancer Res. 42 , 4348-4352, (1982)]
2013-06-01
[Diabetes 62(6) , 2026-35, (2013)]
2009-01-16
[Immunity 30(1) , 56-66, (2009)]
2013-01-01
[Plant Physiol. 161(1) , 556-67, (2013)]